Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism
Serum melatonin and its main metabolic product 6‐sulfatoxymelatonin were determined in 17 patients with breast cancer (BC) with either a fresh primary tumor (nine) or a secondary tumor (eight) as well as in four patients with untreated benign breast disease (controls). Circadian rhythms were detecte...
Gespeichert in:
Veröffentlicht in: | Cancer 1991-03, Vol.67 (6), p.1681-1684 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!